Literature DB >> 16181056

Serine phosphorylation of Stat6 negatively controls its DNA-binding function.

Nilesh R Maiti1, Pankaj Sharma, Phyllis C Harbor, S Jaharul Haque.   

Abstract

In response to interleukin-4 (IL-4) or IL-13 stimulation of cells, Stat6 becomes phosphorylated on Tyr(641) and forms homodimers that migrate to the nucleus, bind to cognate DNA elements, and drive the transcription of target genes. Here, we show that phosphorylation of multiple serine residues ablates its DNA-binding activity in IL-4 stimulated cells. The phosphorylation sites are mapped to the transactivation domain (TAD) of Stat6. Importantly, serine phosphorylation of Stat6 TAD does not affect the phosphorylation of Tyr(641), nor does it affect the dimer formation or the ability of translocating to the nucleus in IL-4-stimulated cells. Collectively, these data suggest that phosphorylation of multiple serine residues in the TAD possibly induces conformational changes in Stat6 dimers that cause the loss of DNA binding and, thus, negatively control the expression of IL-4-responsive genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181056     DOI: 10.1089/jir.2005.25.553

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  12 in total

1.  Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

Authors:  Geetanjali Kharmate; Zhongfeng Liu; Eric Patterson; Manzoor M Khan
Journal:  Int Immunopharmacol       Date:  2006-11-20       Impact factor: 4.932

2.  Deactivation of STAT6 through serine 707 phosphorylation by JNK.

Authors:  Takashi Shirakawa; Yoshinori Kawazoe; Tomoko Tsujikawa; Dongju Jung; Shin-ichi Sato; Motonari Uesugi
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 3.  Interpreting mixed signals: the cell's cytokine conundrum.

Authors:  Greg M Delgoffe; Peter J Murray; Dario A A Vignali
Journal:  Curr Opin Immunol       Date:  2011-08-16       Impact factor: 7.486

4.  Live cell imaging reveals continuous STAT6 nuclear trafficking.

Authors:  Hui-Chen Chen; Nancy C Reich
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

Review 5.  Targeting the interleukin-6/Jak/stat pathway in human malignancies.

Authors:  Pasquale Sansone; Jacqueline Bromberg
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

6.  Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C.

Authors:  Ming Zhao; Kaiqun Ren; Xiwen Xiong; Yue Xin; Yujie Zou; Jason C Maynard; Angela Kim; Alexander P Battist; Navya Koneripalli; Yusu Wang; Qianyue Chen; Ruyue Xin; Chenyan Yang; Rong Huang; Jiahui Yu; Zan Huang; Zengdi Zhang; Haiguang Wang; Daoyuan Wang; Yihui Xiao; Oscar C Salgado; Nicholas N Jarjour; Kristin A Hogquist; Xavier S Revelo; Alma L Burlingame; Xiang Gao; Jakob von Moltke; Zhaoyu Lin; Hai-Bin Ruan
Journal:  Immunity       Date:  2022-04-05       Impact factor: 43.474

7.  Redox regulation of interleukin-4 signaling.

Authors:  Pankaj Sharma; Rikhia Chakraborty; Lu Wang; Booki Min; Michel L Tremblay; Tsukasa Kawahara; J David Lambeth; S Jaharul Haque
Journal:  Immunity       Date:  2008-10-17       Impact factor: 31.745

8.  Identification of STAT2 serine 287 as a novel regulatory phosphorylation site in type I interferon-induced cellular responses.

Authors:  Håkan C Steen; Shoko Nogusa; Roshan J Thapa; Suresh H Basagoudanavar; Amanda L Gill; Salim Merali; Carlos A Barrero; Siddharth Balachandran; Ana M Gamero
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

Review 9.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01

10.  Interaction of STAT6 with its co-activator SRC-1/NCoA-1 is regulated by dephosphorylation of the latter via PP2A.

Authors:  Tobias Münz; Claudia M Litterst; Edith Pfitzner
Journal:  Nucleic Acids Res       Date:  2010-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.